Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Sanwa Kagaku Kenkyusho Co., Ltd.

Overview

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Type 2 Diabetes Mellitus

Interventions

MiglitolDRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 69 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type 2 diabetic patients treated with Biguanide * Criteria for postprandial plasma glucose and HbA1c are met Exclusion Criteria: * Type 1 diabetes * Patients treated with other antidiabetic drugs or Insulin

Locations (13)

Unnamed facility

Aichi, Japan

Unnamed facility

Chiba, Japan

Unnamed facility

Fukuoka, Japan

Unnamed facility

Gifu, Japan

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.